Daniel T. Chiu
Director/Board Member at FLUICELL AB
Daniel T. Chiu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FLUICELL AB | Director/Board Member | 01/01/2017 | - |
| Independent Dir/Board Member | 01/01/2017 | - | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 29/10/2009 | - |
MiCareo, Inc.
 MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Founder | 01/01/2011 | - |
Career history of Daniel T. Chiu
Former positions of Daniel T. Chiu
| Companies | Position | Start | End |
|---|---|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Founder | 02/06/2010 | - |
Training of Daniel T. Chiu
| Stanford University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Statistics
International
| United States | 4 |
| Sweden | 3 |
| Taiwan | 2 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FLUICELL AB | Health Technology |
| Private companies | 2 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Daniel T. Chiu
- Experience
